Stars 4.9 111 Patients Satisfaction Reviews 27 comments


Secondary Specialty:

Pediatric Rheumatology

Board Certifications:

Pediatric Rheumatology


MD, Pennsylvania State University College of Medicine Hershey, PA


University of Pittsburgh Medical School
Pittsburgh, PA
University of Pittsburgh School of Medicine
Pittsburgh, PA


University of Pittsburgh Medical School
Pittsburgh, PA
University of Pittsburgh School of Medicine
Pittsburgh, PA


Children's Hospital of Pittsburgh of UPMC

Kathryn Seraphin Torok, MD


Assistant Professor, University of Pittsburgh School of Medicine


Locations and Directions



Research Interests

  • T-helper cell cytokine profile in localized scleroderma
  • Serum cytokine profiles in localized scleroderma
  • Childhood Arthritis and Rheumatic Disease Research Alliance Network (“CARRANet”): Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology
  • Development of Clinical Disease Activity Measures for Pediatric Localized Scleroderma
  • Developing Tools for Localized Scleroderma Comparative Effectiveness Studies

View Dr. Torok's full list of publications from PubMed.

Biography Summary

Kathryn Torok, MD, began her career in Pediatric Rheumatology as a Fellow at the Children’s Hospital of Pittsburgh in 2006. Upon completion of her fellowship, she started as an Instructor in the Division of Rheumatology Pittsburgh in July 2009, and was promoted to Assistant Professor in July 2010. She helped create, implement, and now serves as director of the CHP Scleroderma Clinic which provides treatment for children with localized and systemic scleroderma (LS and ScS).

Along with treating patients, Dr. Torok has been involved in a multitude of research projects including serving as principle investigator and coordinator of the National Registry for Childhood Onset Scleroderma. The registry serves as a national resource of longitudinal data on pediatric patients with this disease and spurs Dr. Torok’s mission to directly stimulate new research and investigations with this patient population. In addition to the registry, Dr. Torok is involved in the Childhood Arthritis and Rheumatic Disease Research Alliance Network (CARRANet), a North American organization of pediatric rheumatologists who are committed to advancing the health and quality of life of children living with rheumatic disease and arthritis and who have joined together to answer critical clinical research questions. She has initiated and participated in a number of studies to further evaluate disease activity measurement in pediatric localized scleroderma, by studying clinical, thermal and ultrasonography measures.

Currently, Dr. Torok’s main research interest is the T-helper cell cytokine profile of patients with localized scleroderma. Her NIH funded project represents the first study to evaluate all three Th cell lineages in LS by measuring their associated cytokines in serum and skin biopsies of patients. Effective anti-cytokine therapies for LS may stem from this proposal, modifying the way clinicians treat this disease and potentially saving children from life-long physical and emotional disability.

Dr. Torok’s long-term research goal is to provide better treatment options for LS by targeting cytokines and other factors associated with the active phase of the disease, to minimize or prevent long-term tissue damage.

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and are displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Total Comments: 27